Search

The German Research Foundation (DFG) will fund single-cell scientist Simon Haas in its Heisenberg program. Therefore, the Berlin Institute of Health at Charité (BIH) is establishing a Heisenberg professorship in systems hematology. After five years, the BIH will make the professorship permanent.

NOVA University and Max Delbrück Center are jointly establishing the NOVA Institute for Medical Systems Biology (NIMSB). Both institutions have developed a shared vision to push the boundaries of precision medicine. “Insights” spoke to the three project leads in Lisbon and Berlin.

Cell-based immunotherapies, particularly lab-produced immune cells known as CAR T cells, show promise in treating various cancers. But how do we produce effective ones? Gaetano Gargiulo from the Max Delbrück Center will develop a novel screening tool, supported by an ERC Proof of Concept Grant.

Working in Berlin-Mitte and New York – Lena Nitsch conducts research at both the MDC-BIMSB and New York University. For “We at the MDC”, the doctoral student discusses how it is to work in two labs, her experiences in the United States, and what she has learned through the “MDC-NYU PhD Exchange Program”.

The European Molecular Biology Organization has selected Leif. S. Ludwig from the Berlin Institute of Health at Charité (BIH) and the Max Delbrück Center to become an EMBO Young Investigator. The program provides support to outstanding young life scientists.

To attract renowned researchers to Berlin, Stiftung Charité is funding “Visiting Fellows” with 1.5 million euros. One of them is Manuel Irimia from Barcelona. He is coming to the Max Delbrück Center for three years to analyze gene regulation.

From 2024, the Federal Government and the State of Berlin will fund the establishment of the National Center for Tumor Diseases (NCT) Berlin. The new site is a cooperation between DKFZ and Charité, BIH, and Max Delbrück Center aimed at closely integrating clinical and translational cancer research.

Simon Haas has been awarded the Lisec-Artz Prize, endowed with €10,000, for his single-cell analysis of communication between stem and immune cells in blood cancer. The University of Bonn Foundation established this prize to honor outstanding early-career cancer researchers.

Organoids help researchers understand biological processes in health and in disease. It is, however, difficult to influence the way in which they organize themselves into complex tissues. Now a group led by Nikolaus Rajewsky has found a new way to do so. They report their work in Nature Methods.

Scientists have created a new zebrafish xenograft platform to screen for novel treatments for an aggressive brain tumor called glioblastoma, according to a new study by the Gerhardt and De Smet labs published in “EMBO Molecular Medicine.”